Cargando…
Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines
BACKGROUND: Two cytidine analogues, gemcitabine and cytosine arabinoside (AraC), are widely used in the treatment of a variety of cancers with a large individual variation in response. To identify potential genetic biomarkers associated with response to these two drugs, we used a human lymphoblastoi...
Autores principales: | Li, Liang, Fridley, Brooke L, Kalari, Krishna, Niu, Nifang, Jenkins, Gregory, Batzler, Anthony, Abo, Ryan P, Schaid, Daniel, Wang, Liewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930546/ https://www.ncbi.nlm.nih.gov/pubmed/24483146 http://dx.doi.org/10.1186/1471-2164-15-93 |
Ejemplares similares
-
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study
por: Niu, Nifang, et al.
Publicado: (2012) -
Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
por: Tong, Yin, et al.
Publicado: (2015) -
Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
por: Jiang, Jing, et al.
Publicado: (2013) -
Copy number variation and cytidine analogue cytotoxicity: A genome-wide association approach
por: Kalari, Krishna R, et al.
Publicado: (2010) -
Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)